Shattuck Labs, Inc. financial data

Symbol
STTK on Nasdaq
Industry
Pharmaceutical Preparations
Location
500 W. 5 Th Street, Austin, TX
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Mar 27, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 836 % -17.2%
Debt-to-equity 14.9 % +19.2%
Return On Equity -72.6 % -15.1%
Return On Assets -63.1 % -12.6%
Operating Margin -1.41K % +74.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 47.9M shares +0.73%
Common Stock, Shares, Outstanding 47.7M shares +0.96%
Entity Public Float 102M USD +19.3%
Common Stock, Value, Issued 5K USD 0%
Weighted Average Number of Shares Outstanding, Basic 50.8M shares +19.2%
Weighted Average Number of Shares Outstanding, Diluted 50.8M shares +19.2%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 5.72M USD +245%
Research and Development Expense 67.2M USD -9.55%
General and Administrative Expense 19.1M USD -1.18%
Operating Income (Loss) -80.6M USD +12.4%
Net Income (Loss) Attributable to Parent -75.4M USD +13.6%
Earnings Per Share, Basic -1.49 USD/shares +27.3%
Earnings Per Share, Diluted -1.49 USD/shares +27.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 57.4M USD -54.3%
Cash, Cash Equivalents, and Short-term Investments 73M USD -44.1%
Assets, Current 79.2M USD -44.7%
Property, Plant and Equipment, Net 9.81M USD -28.9%
Operating Lease, Right-of-Use Asset 1.84M USD -18.8%
Other Assets, Noncurrent 2.02M USD -20.4%
Assets 91M USD -42.9%
Accounts Payable, Current 2.42M USD +52.4%
Employee-related Liabilities, Current 2.29M USD -39.7%
Contract with Customer, Liability, Current 3M USD +303%
Liabilities, Current 8.92M USD -22.1%
Operating Lease, Liability, Noncurrent 2.51M USD -26.4%
Liabilities 11.4M USD -23.1%
Accumulated Other Comprehensive Income (Loss), Net of Tax 2K USD -50%
Retained Earnings (Accumulated Deficit) -382M USD -24.6%
Stockholders' Equity Attributable to Parent 79.6M USD -45%
Liabilities and Equity 91M USD -42.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -16.2M USD +38.9%
Net Cash Provided by (Used in) Financing Activities -184K USD
Net Cash Provided by (Used in) Investing Activities -33.3M USD -174%
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 47.7M shares +0.96%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -49.6M USD -366%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 57.4M USD -54.3%
Deferred Tax Assets, Valuation Allowance 95.6M USD +25.2%
Deferred Tax Assets, Gross 96.8M USD +24.2%
Operating Lease, Liability 3.41M USD -18.9%
Depreciation 974K USD -3.95%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -75.4M USD +12.7%
Lessee, Operating Lease, Liability, to be Paid 3.97M USD -22%
Property, Plant and Equipment, Gross 23M USD -1.21%
Operating Lease, Liability, Current 900K USD +13.1%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.09M USD -5.12%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.15M USD +2.86%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 561K USD -36.5%
Lessee, Operating Lease, Liability, to be Paid, Year Three 848K USD -22.4%
Deferred Tax Assets, Operating Loss Carryforwards 41.1M USD +31%
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 4.21M USD +29.1%
Lessee, Operating Lease, Liability, to be Paid, Year Four 874K USD +3.07%
Additional Paid in Capital 461M USD +2.29%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 1.2M USD -23%
Share-based Payment Arrangement, Expense 9.55M USD +37.6%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%